|
Search
Collections
Benchmarks
Upload document
Product
IMS001
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Multiple Sclerosis
Clinical trial
A Phase 1, Dose-Escalating, Open-label Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of Single Dose of IV IMS001 in Subjects With Multiple Sclerosis and Treatment Failure to Prior Disease Modifying Treatments (DMTs)
Status: Recruiting
, Estimated PCD: 2027-12-01